Time mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations, rather than sex, estradiol, or menstrual cycle stage, primarily determine the GH elimination rate in healthy young women and men

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 8, 1999, Pages 2862-2869

  Shah, N ^a,c   Aloi, J ^a   Evans, W S ^a   Veldhuis, J D ^a,b  

^a NATIONAL SCIENCE FOUNDATION   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GROWTH HORMONE; HUMAN GROWTH HORMONE; OCTREOTIDE; PROGESTERONE;

ADULT; ARTICLE; BODY SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HALF LIFE TIME; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; MALE; MENSTRUAL CYCLE; METABOLIC CLEARANCE RATE; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0033323799     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.8.2862     Document Type: Article

References (47)

1. Operating behavior of dual or multiple endocrine pulse generators
2. Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human
3. Contemporary aspects of discrete peak detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men
4. How does one get at glandular secretion, when only hormone concentrations are measured?
5. Disappearance of human growth hormone in the anephric non-uraemic and uraemic rat
6. Metabolic clearance of human growth hormone in patients with hepatic and renal failure and in the isolated perifused pig liver
7. Altered endogenous growth factor (GH) secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease
8. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure
9. Renal extraction, filtration, absorption, and catabolism of growth hormone
10. Studies on the metabolic clearance rate, apparent distribution space and plasma half-disappearance time of unlabelled human growth hormone in normal subjects and in patients with liver disease, renal disease, thyroid disease and diabetes mellitus
11. Multifactorial control of the elimination kinetics of unbound (free) GH in the human: Regulation by age, adiposity, renal function, and steady-state concentrations of GH in plasma
12. Metabolic clearance rates of synthetic human growth hormone in lean and obese male rhesus monkeys
13. Metabolic clearance rates of synthetic human growth hormone in children, adult women, and adult men
14. Diurnal variation of the elimination of human growth hormone: The serum half-life is prolonged in the evening and affected by the source of the hormone, as well as by body size and serum estradiol
15. Sex steroids, growth hormone, IGF-I: Neuroendocrine and metabolic regulation in puberty
16. Gender differences in secretory activity of the human somatotropic (growth hormone) axis
17. New modalities for understanding dynamic regulation of the somatotropic (GH) axis: Explication of gender differences in GH neuro-regulation in the human
18. An amplitude-specific divergence in the pulsatile mode of GH secretion underlies the gender difference in mean GH concentrations in men and premenopausal women
19. Pulsatile growth hormone release in normal women during the menstrual cycle
20. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the preovulatory interval in normal women
21. Hormonal relationships during the menstrual cycle
22. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
23. Growth hormone economy in normally cycling women
24. Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion
25. Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH
26. Differential impact of age, sex-steroid hormones, and obesity on basal vs. pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay
27. Endogenous growth hormone secretion and clearance rates in normal boys as determined by deconvolution analysis: Relationship to age, pubertal status and body mass
28. Characteristics of luteinizing hormone secretion in younger vs. older premenopausal women
29. Effects of age on the irregularity of LH and FSH serum concentrations in women and men
30. The pituitary gland secretes in bursts: Appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations
31. Deconvolution analysis of hormone data
32. Specific methodological approaches to selected contemporary issues in deconvolution analysis of pulsatile neuroendocrine data
33. Metabolic clearance of biologically active luteinizing hormone in man
34. Relationship between age, percentage body fat, fitness and 24 hour growth hormone release in healthy young adults: Effects of gender
35. Joint recovery of pulsatile and basal hormone secretion by stochastic nonlinear random-effects analysis
36. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin
37. Temporal structure of in vivo growth hormone secretory events in man
38. Determination of integrated plasma concentration and true secretion rates of human growth hormone
39. Metabolic clearance and production rates of human growth hormone
40. Renal clearance; metabolic clearance rate, and half-life of human growth hormone in young and aged subjects
41. Assessment of growth hormone (GH) plasma clearance rate, half-life, and volume of distribution in acromegalic patients: The combined GH-octreotide infusion
42. Pharmacokinetics and short-term metabolic effects of mammalian cell-derived biosynthetic human growth hormone in man
43. Plasma clearance of intravenously administered pituitary human growth hormone: Gel filtration studies of heterogeneous components
44. The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin
45. Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth
46. Analysis of nonequilibrium dynamics of bound, free, and total plasma ligand concentrations over time following nonlinear secretory inputs: Evaluation of the kinetics of two or more hormones pulsed into compartments containing multiple variable-affinity binding proteins
47. Variability in the quantitation of circulating growth hormone using commerical imununoassays